Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
The New York Times - 4 Sep 2026 23:22
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Share this Article
Recommended